Editas Medicine, Inc. 4
4 · Editas Medicine, Inc. · Filed Oct 6, 2016
Insider Transaction Report
Form 4
Cox Gerald Frank
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2016-10-05+225,000→ 225,000 totalExercise: $15.48Exp: 2026-10-04→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]This option was granted on October 5, 2016 and is scheduled to vest over four years with 25% of the shares scheduled to vest on October 3, 2017, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 3, 2020.